Luivac

Medicinal product

(Invented) name

Luivac

Active substance (s)

Bakterijų (Staphylococcus aureus, Streptococcus mitis/pyogenes/pneumoniae, Klebsiella pneumoniae, Branhamella catarrhalis ir Haemophilus influenzae) lizatas

Strength

3 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

L03AX, Other immunostimulants

Marketing authorisation holder

Daiichi Sankyo Europe GmbH, Vokietija

Date of authorisation

1998-11-27

Date of renewal

2014-03-27

Documents

3530_1_Luivac_3mg_tab_RPP_200427.doc

3530_1_Pakuotes lapelis_200427.docx

Stage

Išregistruotas

Controlled?

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Bakterijų (Staphylococcus aureus, Streptococcus mitis/pyogenes/pneumoniae, Klebsiella pneumoniae, Branhamella catarrhalis ir Haemophilus influenzae) lizatas	3 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
9538	14180	1014180	lizdinė plokštelė	N28		Receptinis	LT/1/98/3530/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2022-05-27	Išregistruotas
2014-03-27	Perregistruotas
1998-11-27	Registruotas